Key facts
- 1315 Capital’s last known valuation is $299.2M.
- Notable investors include Navigator Global Investments.
- Status: Privately Held (backing).
Leadership
- Adele OlivaCo-Founder, Partner & Member of Investment Team
- Michael KobyCo-Founder, Partner & Investment Executive
- Russ RapaportAssociate
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for 1315 Capital
- ·The full record, as it builds
Funding rounds
No funding rounds for 1315 Capital are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 1315 Capital
Provider of expansion and growth capital catering to commercial-stage healthcare services, medical technology, medtech & pharma outsourcing, and health & wellness companies. The company provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology and healthcare services companies, the latter including businesses focused on cost containment and digital health and leveraging an operating partner model of CEO and COO Executive, a partnership that works together to navigate diligence, drive decisions, and seeks to achieve premium exits.
- Sector
- Financial Services
- HQ
- Philadelphia, PA, United States
- Employees
- 27
- Website
- 1315capital.com/
- Ownership
- Privately Held (backing)
1315 Capital doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 1315 Capital shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 1315 Capital in its N-PORT filings yet. We sweep new filings monthly.